NYSEAMERICAN:BPMX - Biopharmx Stock Price, Forecast & News

Biopharmx trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "BPMX."

Shares of Biopharmx reverse split on the morning of Friday, April 26th 2019. The 1-25 reverse split was announced on Monday, April 15th 2019. The number of shares owned by shareholders was adjusted after the market closes on Thursday, April 25th 2019. An investor that had 100 shares of Biopharmx stock prior to the reverse split would have 4 shares after the split.

Biopharmx Corp (NYSEAMERICAN:BPMX) posted its quarterly earnings results on Monday, September, 9th. The biotechnology company reported ($0.22) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.33) by $0.11. View Biopharmx's Earnings History.

2 analysts have issued twelve-month target prices for Biopharmx's stock. Their forecasts range from $1.00 to $1.00. On average, they expect Biopharmx's stock price to reach $1.00 in the next twelve months. This suggests a possible upside of 158.9% from the stock's current price. View Analyst Price Targets for Biopharmx.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Biopharmx in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Biopharmx.

Media stories about BPMX stock have trended somewhat positive on Saturday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Biopharmx earned a coverage optimism score of 0.7 on InfoTrie's scale. They also gave news articles about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Biopharmx.

Some companies that are related to Biopharmx include Crescita Therapeutics (CTX), Skinbiotherapeutics (SBTX), Quest PharmaTech (QPT), BTC Health (BTC), Destiny Pharma (DEST), Bio-Gene Technology (BGT), Race Oncology (RAC), Adalta (1AD), Fusion Antibodies (FAB), NovaBay Pharmaceuticals (NBY), Navidea Biopharmaceuticals (NAVB), Navidea Biopharmaceuticals (NAVB), C4X Discovery (C4XD), Suda Pharmaceuticals (SUD) and Collagen Solutions (COS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Biopharmx investors own include Sarepta Therapeutics (SRPT), Netlist (NLST), Neovasc (NVCN), Hawkins (HWKN), CytRx (CYTR), Novavax (NVAX), Synergy Pharmaceuticals (SGYP), Rexahn Pharmaceuticals (REXN), Protalix Biotherapeutics (PLX) and Jaguar Health (JAGX).

Biopharmx's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Barclays PLC (1.23%) and Virtu Financial LLC (0.71%). Company insiders that own Biopharmx stock include Anja B Krammer, David S Tierney, Stephen Morlock and Vivo Capital Viii, Llc. View Institutional Ownership Trends for Biopharmx.

BPMX stock was sold by a variety of institutional investors in the last quarter, including Virtu Financial LLC. Company insiders that have sold Biopharmx company stock in the last year include Anja B Krammer and Vivo Capital Viii, Llc. View Insider Buying and Selling for Biopharmx.

BPMX stock was purchased by a variety of institutional investors in the last quarter, including Barclays PLC. View Insider Buying and Selling for Biopharmx.

Shares of BPMX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BPMX stock can currently be purchased for approximately $0.39.

Biopharmx has a market capitalization of $5.48 million. Biopharmx employs 17 workers across the globe.View Additional Information About Biopharmx.

The official website for Biopharmx is http://www.biopharmx.com/.

Biopharmx's mailing address is 1505 Adams Dr Ste D, MENLO PARK, CA 94025-1451, United States. The biotechnology company can be reached via phone at +1-650-8895020.